Skip to main content
Equibles

ALGERT GLOBAL LLC

Position in VIR — Vir Biotechnology, Inc.

CIK 1275218 SAN FRANCISCO, CA
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,202,715
+$3,821,204 QoQ
Shares Held
804,977
+64.6% QoQ
Ownership
0.476%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#32
of 237 holders
Holding Since
Sep 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. VIR ranks #28 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PCVX
Vaxcyte, Inc.
 515,343 $29,956,888
2 ROIV
Roivant Sciences Ltd.
 845,118 $29,908,726
3 XENE
Xenon Pharmaceuticals Inc.
 419,773 $25,337,498
4 CLDX
Celldex Therapeutics, Inc.
 647,836 $24,105,977
5 AXSM
Axsome Therapeutics, Inc.
 95,335 $23,335,147
6 SNDX
Syndax Pharmaceuticals Inc
 1,051,465 $22,985,024
7 MRNA
Moderna, Inc.
 274,820 $19,245,644
8 MLYS
Mineralys Therapeutics, Inc.
 649,027 $17,510,748

All Filings in VIR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,202,715 804,977
2026-03-31 $4,381,511 489,008
2025-06-30 $99,802 19,802
2025-03-31 $128,316 19,802
2024-12-31 $145,346 19,802
2024-09-30 $1,598,852 213,465
2024-06-30 $1,484,831 166,835
2023-12-31 $321,517 31,960
2023-09-30 $4,213,548 449,685
2022-12-31 $417,868 16,510
2022-03-31 $500,639 19,465
2021-12-31 $298,072 7,119
2021-09-30 $355,514 8,169